At Elicio, we’re excited about our work, and look forward to sharing information about it with you. Please feel free to get in touch with us.
451 D Street
5th Floor, Suite 501
Boston, MA 02210
USA
Email: info@elicio.com
Phone: +1 857 209-0050
For information about our clinical trials, please visit ClinicalTrials.gov.
AMPLIFY-201: First in Human Phase 1/2 Trial of ELI-002 Immunotherapy as Treatment for Subjects With Kirsten Rat Sarcoma (KRAS) Mutated Pancreatic Ductal Adenocarcinoma and Other Solid Tumors (Protocol Number: ELI-002-001)
Enrolling RAS mutated pancreatic, colorectal, lung, mucinous ovarian, bile duct and gallbladder tumors
For further questions about the trials, contact one of our participating sites listed on ClinicalTrials.gov
